Summary
Updated Aug 30, 2026
Margaret A. Alexander is President and CEO of Ovid Therapeutics Inc. (OVID). 1 SEC Form 4 filing on record, dated 2 March 2026. Most recent open-market trade: sold $17K of OVID on 2 March 2026. Lifetime open-market sales: $17K.
Recent Transactions
1Every recent SEC Form 4 transaction Margaret A. Alexander has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Margaret A. Alexander go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Margaret A. Alexander files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey A. Rona - $12K of OVID open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Margaret A. Alexander?
Margaret A. Alexander is a corporate insider, tracked as President and CEO of Ovid Therapeutics Inc. (OVID). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Margaret A. Alexander last file a Form 4?
The only primary Form 4 on record is dated 2 March 2026.
Has Margaret A. Alexander been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($17K) across all tracked filings.
Where can I see all of Margaret A. Alexander's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Margaret A. Alexander and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial